Skip to Main Content

Author Details

Anat Stemmer-Rachamimov
Massachusetts General Hospital
1997
189
60
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36413215Cell-Mediated Cytotoxicity in Lyme Arthritis.Arthritis Rheumatol2023
38015025Spontaneous rupture of an arachnoid cyst in an adult: illustrative case.J Neurosurg Case Lessons2023
37215956Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.Neurooncol Adv2023
37048724Comparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus.J Clin Med2023
37330719Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.J Invest Dermatol2023
36798353Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain.bioRxiv2023
34128391The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.Hum Gene Ther2022
35846573Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.Mol Ther Methods Clin Dev2022
35674741Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.Genet Med2022
36400878Fast-acting and injectable cryoneurolysis device.Sci Rep2022
36132994Full Recovery after Multiple Treatments with Injectable Ice Slurry.J Pain Res2022
36358494Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice.Antioxidants (Basel)2022
36267257Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.Open Forum Infect Dis2022
35218117N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).Genes Chromosomes Cancer2022
35243413Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.Cell Rep Med2022
33025139Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.Acta Neuropathol2021
33523984Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin.Sci Adv2021
34041811Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.Oncologist2021
34012067Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.Genet Med2021
34264955Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.PLoS One2021
34261799Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.Sci Transl Med2021
34053190Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.Ann Clin Transl Neurol2021
34230199Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.Neurology2021
33112994Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.Acta Neuropathol2021
33221867A case of antisynthetase syndrome with thrombotic thrombocytopenic purpura.Rheumatology (Oxford)2021
31161239An update on the CNS manifestations of neurofibromatosis type 2.Acta Neuropathol2020
31977524Neural Selective Cryoneurolysis with Ice Slurry Injection in a Rat Model.Anesthesiology2020
33308315Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.Acta Neuropathol Commun2020
32923170IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.Oncoimmunology2020
31432207Correction to: An update on the CNS manifestations of neurofibromatosis type 2.Acta Neuropathol2020
30531646Vestibular Traumatic Neuroma Following Temporal Bone Fracture.Otol Neurotol2019
31653841Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration.Nat Commun2019
32642737Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.Neurooncol Adv2019
31430634NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss.Hear Res2019
31534984Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1.Mol Ther Methods Clin Dev2019
31154686Myositis associated with carbon monoxide poisoning.Undersea Hyperb Med2019
30977509Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.Neuro Oncol2019
30633907Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.Cell2019
30335132A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.Hum Mol Genet2019
28621619Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.J Neurosurg2018
30123936DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.Acta Neuropathol2018
29987130Cutaneous neurofibromas: Current clinical and pathologic issues.Neurology2018
29982664EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.Neuro Oncol2018
29897904Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.PLoS One2018
30388456Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.Cell2018
30302402Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.Commun Biol2018
29774626Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings.Hum Mutat2018
29440379Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.Proc Natl Acad Sci U S A2018
29438698Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.Cancer Cell2018
29767307Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.J Neurooncol2018
  • 1 - 50 of 189

Recommended Authors

Calixto-Hope G Lucas
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 8
Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Nitin R Wadhwani
Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 2
Matthew D Wood
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 7
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 3
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 2
David A Solomon
University of California san francisco
Career Start Year 2003
Number of shared co-authors 14
Mariza Daras
University of California san francisco
Career Start Year 2001
Number of shared co-authors 11
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 11
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 1
Angela C Hirbe
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 9
Mariarita Santi
Children's Hospital of Philadelphia
Career Start Year 1997
Number of shared co-authors 20
Stephan Frank
Universitatsspital Basel
Career Start Year 1996
Number of shared co-authors 13
Jorge A Gutierrez
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Career Start Year 1994
Number of shared co-authors 1
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Career Start Year 1993
Number of shared co-authors 27
Johannes A Hainfellner
Medical University of Vienna
Career Start Year 1992
Number of shared co-authors 3
Alexander O Vortmeyer
Indiana University School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 17
Wies??awa Grajkowska
Children's Memorial Health Institute
Career Start Year 1987
Number of shared co-authors 15
Ho-Keung Ng
Chinese University of Hong Kong
Career Start Year 1987
Number of shared co-authors 17
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 6
David W Ellison
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 22
John Provias
McMaster University
Career Start Year 1986
Number of shared co-authors 5
Caterina Giannini
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 39
James T Rutka
Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 18
William Halliday
University of Toronto
Career Start Year 1984
Number of shared co-authors 5
Cynthia Hawkins
The Hospital for Sick Children
Career Start Year 1980
Number of shared co-authors 31
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 19
Pascale Varlet
Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM, University of Paris
Career Start Year 1963
Number of shared co-authors 14

Collaborators

David N Louis
Co-authored papers 24
Jaishri O Blakeley
Johns Hopkins University
Co-authored papers 16
James F Gusella
Co-authored papers 14
Xandra O Breakefield
Massachusetts General Hospital
Co-authored papers 14
Rebecca A Betensky
New York University.
Co-authored papers 9
David H Gutmann
Co-authored papers 8
Sandro Santagata
Co-authored papers 8
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 7
Tracy T Batchelor
Brigham and Women's Hospital
Co-authored papers 7
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 7
Priscilla K Brastianos
Co-authored papers 7
Declan McGuone
Smilow Cancer Hospital
Co-authored papers 5
Paul Van Hummelen
Co-authored papers 5
Brigitte C Widemann
Co-authored papers 5
Rameen Beroukhim
Co-authored papers 5
David A Largaespada
University of Minnesota
Co-authored papers 5
Ian F Dunn
Co-authored papers 4
Mai P Hoang
Co-authored papers 4
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Co-authored papers 4
Aaron R Thorner
Co-authored papers 4
Stephen J Haggarty
Co-authored papers 4
Gary L Johnson
Co-authored papers 4
Keith L Ligon
Co-authored papers 4
Robert T Jones
Co-authored papers 4
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
Peleg M Horowitz
Co-authored papers 4
Keren Yizhak
Co-authored papers 4
Michael J Fisher
Co-authored papers 4
Nir Hacohen
Broad Institute of MIT and Harvard
Co-authored papers 4
Matthew Meyerson
Broad Institute
Co-authored papers 4
Release 1.2